Van Niel, Maureen Sayres MD; Bhatia, Richa MD; Riano, Nicholas S. MAS; de Faria, Ludmila MD; Catapano-Friedman, Lisa MD; Ravven, Simha MD; Weissman, Barbara MD; Nzodom, Carine MD; Alexander, Amy MD; Budde, Kristin MD, MPH; Mangurian, Christina MD, MAS
From the Department of Psychiatry, Weill Institute for Neurosciences (Mr. Riano and Dr. Mangurian), and Philip R. Lee Institute for Health Policy Studies (Dr. Mangurian), University of California, San Francisco; Florida State University College of Medicine (Dr. de Faria); Massachusetts College of Pharmacy and Health Sciences (Dr. Catapano-Friedman); Yale University School of Medicine (Drs. Ravven and Budde); San Mateo County Psychiatry Residency Training Program (Dr. Weissman); Columbia University School of Medicine (Dr. Nzodom); Stanford University School of Medicine (Dr. Alexander).
Original manuscript received 1 February 2019; revised manuscript received 13 September 2019, accepted for publication subject to revision 8 October 2019; revised manuscript received 4 November 2019.
Correspondence: Christina Mangurian, MD, MAS, UCSF Department of Psychiatry at Zuckerberg San Francisco General Hospital, 1001 Potrero Ave., Suite 7M, San Francisco, CA 94110. [email protected]